{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:29:56Z","timestamp":1792466996989,"version":"4.5.0"},"reference-count":192,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA18227"],"award-info":[{"award-number":["CA18227"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.568598","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T14:07:50Z","timestamp":1604412470000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy"],"prefix":"10.3389","volume":"11","author":[{"given":"Ann-Marie Malby","family":"Schoos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Lund","family":"Chawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselot","family":"De Vlieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"DunnGalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Garssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Hilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Knipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kuehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Mijakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Munblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita A.","family":"Nekliudov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevdet","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Patient","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Peroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasho","family":"Stoleski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Tukalj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty","family":"Verhoeckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Zidarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"van de Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1040","article-title":"State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous","volume":"133","author":"Jones","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.nutres.2011.01.001","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report","volume":"31","author":"Boyce","year":"2011","journal-title":"Nutr Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.iac.2019.09.010","article-title":"Highlights of Novel Vaccination Strategies in Allergen Immunotherapy","volume":"40","author":"Koml\u00f3si","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.06.026","article-title":"Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens","volume":"121","author":"G\u0142obi\u0144ska","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12869","article-title":"Safety and efficacy of epicutaneous immunotherapy for food allergy","volume":"29","author":"Wang","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.12.008","article-title":"Harmonization of Terminology for Tolerated and Reactive Dose in Food Allergy Immunotherapy","volume":"7","author":"Casale","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124607","article-title":"The use of biologics for immune modulation in allergic disease","volume":"130","author":"van de Veen","year":"2019","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.1.e6","article-title":"Clinical features of acute allergic reactions to peanut and tree nuts in children","volume":"102","author":"Sicherer","year":"1998","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaci.2008.10.011","article-title":"Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model","volume":"123","author":"Ganeshan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jaci.2011.06.007","article-title":"Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner","volume":"128","author":"Dunkin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75660","article-title":"Skin exposure promotes a Th2-dependent sensitization to peanut allergens","volume":"124","author":"Tordesillas","year":"2014","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13486","article-title":"Indoor dust acts as an adjuvant to promote sensitization to peanut through the airway","volume":"49","author":"Smeekens","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.10.007","article-title":"Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy","volume":"135","author":"Brough","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13223-016-0161-x","article-title":"Predictors of allergen sensitization in Singapore children from birth to 3\u00a0years","volume":"12","author":"Loo","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.30","article-title":"Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium","volume":"6","author":"Mabbott","year":"2013","journal-title":"Mucosal Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2010.5","article-title":"Multiple facets of intestinal permeability and epithelial handling of dietary antigens","volume":"3","author":"M\u00e9nard","year":"2010","journal-title":"Mucosal Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091925","article-title":"Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions","volume":"206","author":"Schulz","year":"2009","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/all.13813","article-title":"Langerhans cells mediate the skin-induced tolerance to ovalbumin via Langerin in a murine model","volume":"74","author":"Luo","year":"2019","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01951","article-title":"Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice","volume":"9","author":"Dioszeghy","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1038\/s41467-018-07716-7","article-title":"PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs","volume":"9","author":"Tordesillas","year":"2018","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier Epithelial Cells and the Control of Type 2 Immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jaci.2012.08.002","article-title":"IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization","volume":"131","author":"Chu","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat5943","article-title":"Human \u201cTH9\u201d cells are a subpopulation of PPAR-\u03b3+ TH2 cells","volume":"4","author":"Micoss\u00e9","year":"2019","journal-title":"Sci Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00049","article-title":"Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma","volume":"5","author":"Florence","year":"2018","journal-title":"Front Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/all.12846","article-title":"Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity","volume":"71","author":"Simon","year":"2016","journal-title":"Allergy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jaci.2009.09.048","article-title":"Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses","volume":"124","author":"Prussin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.01.021","article-title":"TH9 cells are required for tissue mast cell accumulation during allergic inflammation","volume":"136","author":"Sehra","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaci.2014.06.032","article-title":"IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy","volume":"134","author":"Brough","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular Helper Cell Biology: A Decade of Discovery and Diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60309-8","article-title":"IgE-mediated food allergy in children","volume":"382","author":"Longo","year":"2013","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1126\/science.aaw6433","article-title":"Identification of a T follicular helper cell subset that drives anaphylactic IgE","author":"Gowthaman","year":"2019","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jaci.2012.04.039","article-title":"Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2","volume":"130","author":"Novak","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2012.04028.x","article-title":"Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children","volume":"42","author":"Thyagarajan","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coi.2017.08.012","article-title":"Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy","volume":"48","author":"van de Veen","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 Oral Immunotherapy for Peanut Allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.02.011","article-title":"An update on the controversy around offering oral immunotherapy to peanut-allergic children outside of research","volume":"122","author":"Soller","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2017.11.004","article-title":"Treatment for food allergy","volume":"141","author":"Burks","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.11.049","article-title":"Current and Future Treatment of Peanut Allergy","volume":"7","author":"Vickery","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4168\/aair.2018.10.3.189","article-title":"Allergen-Specific Immunotherapies for Food Allergy","volume":"10","author":"Feuille","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03948.x","article-title":"Oral immunotherapy for IgE-mediated cow\u2019s milk allergy: a systematic review and meta-analysis","volume":"42","author":"Bro\u017cek","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010638.pub3","article-title":"Oral and sublingual immunotherapy for egg allergy","volume":"4","author":"Romantsik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.045","article-title":"A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol","volume":"145","author":"Kim","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jaci.2018.08.041","article-title":"Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy","volume":"143","author":"Nowak-W\u0119grzyn","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.jaip.2019.05.031","article-title":"Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study","volume":"7","author":"Nachshon","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/S0007114513002353","article-title":"Effectiveness and safety of orally administered immunotherapy for food allergies: a systematic review and meta-analysis","volume":"111","author":"Nurmatov","year":"2014","journal-title":"Br J Nutr"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"Wood RA. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1917","article-title":"Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial","volume":"135","author":"Burks","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2016.08.017","article-title":"Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults","volume":"139","author":"Jones","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16591","article-title":"Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial","volume":"318","author":"Sampson","year":"2017","journal-title":"JAMA"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-10-1","article-title":"Safety and feasibility of oral immunotherapy to multiple allergens for food allergy","volume":"10","author":"B\u00e9gin","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"Sampson HA. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow\u2019s milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: A randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jaip.2017.08.013","article-title":"Quality of life for parents of children with food allergy in peanut-restricted versus peanut-free schools in the United States and Canada","volume":"6","author":"Patel","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.05.026","article-title":"The prevalence of food allergy: a meta-analysis","volume":"120","author":"Rona","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaip.2019.10.045","article-title":"Oral Immunotherapy for Hazelnut Allergy: A Single-Center Retrospective Study on 100 Patients","volume":"8","author":"Moraly","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/0394632017697986","article-title":"Side effects and their impact on the success of milk oral immunotherapy (OIT) in children","volume":"30","author":"Mori","year":"2017","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12901","article-title":"The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions","volume":"47","author":"Gomez","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01921.x","article-title":"Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract","volume":"64","author":"Fern\u00e1ndez-Rivas","year":"2009","journal-title":"Allergy"},{"key":"B66","article-title":"Sublingual immunotherapy in peach allergy: monitoring molecular sensitizations and reactivity to apple fruit and Platanus pollen","volume":"20","author":"Garc\u00eda","year":"2010","journal-title":"J Invest Allergol Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.09.030","article-title":"Wood RA. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow\u2019s milk allergy","volume":"122","author":"Skripak","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00542.x","article-title":"A protocol for oral desensitization in children with IgE-mediated cow\u2019s milk allergy","volume":"59","author":"Meglio","year":"2004","journal-title":"Allergy"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12604","article-title":"Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children","volume":"45","author":"Escudero","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2018.07.007","article-title":"Successful oral desensitization in children with cow\u2019s milk anaphylaxis: Clinical and laboratory evaluation up to nine-years follow-up","volume":"47","author":"Alves-Correia","year":"2019","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03804.x","article-title":"Mechanisms of immunotherapy to aeroallergens","volume":"41","author":"Shamji","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell FcepsilonRI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.06.006","article-title":"Mast cells and basophils in allergic inflammation","volume":"54","author":"Kubo","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301283280408","article-title":"New concepts about the mast cell","volume":"328","author":"Galli","year":"1993","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1417711","article-title":"The role of basophils as innate immune regulatory cells in allergy and immunotherapy","volume":"14","author":"Chirumbolo","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.10.042","article-title":"Multifaceted roles of basophils in health and disease","volume":"142","author":"Karasuyama","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.02.004","article-title":"Regulation of the pleiotropic effects of tissue-resident mast cells","volume":"144","author":"Huber","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12627","article-title":"Human mast cells and basophils-How are they similar how are they different","volume":"282","author":"Varricchi","year":"2018","journal-title":"Immunol Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1369\/0022155414545334","article-title":"Mast cell function: a new vision of an old cell","volume":"62","author":"da Silva","year":"2014","journal-title":"J Histochem Cytochem"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0327","article-title":"Mast Cells as Key Players in Allergy and Inflammation","volume":"28","author":"Gonz\u00e1lez-de-Olano","year":"2018","journal-title":"J Invest Allergol Clin Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00494","article-title":"Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives","volume":"10","author":"Beck","year":"2019","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12639","article-title":"Biomarkers for evaluation of mast cell and basophil activation","volume":"282","author":"Kabashima","year":"2018","journal-title":"Immunol Rev"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40413-016-0094-3","article-title":"Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases","volume":"9","author":"Metcalfe","year":"2016","journal-title":"World Allergy Organ J"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000184","article-title":"Biomarkers of anaphylaxis, beyond tryptase","volume":"15","author":"Sala-Cunill","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11882-018-0831-5","article-title":"Basophil Activation Test: Old and New Applications in Allergy","volume":"18","author":"Hemmings","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.iac.2017.09.004","article-title":"Diagnosis of Food Allergy","volume":"38","author":"Gupta","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"B90","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jaci.2018.01.043","article-title":"Mast cell activation test in the diagnosis of allergic disease and anaphylaxis","volume":"142","author":"Bahri","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.09.001","article-title":"Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut","volume":"135","author":"Santos","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000441","article-title":"How to diagnose food allergy","volume":"18","author":"Sato","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02744.x","article-title":"Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy","volume":"67","author":"Kopac","year":"2012","journal-title":"Allergy"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaci.2017.03.028","article-title":"Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy","volume":"140","author":"Frischmeyer-Guerrerio","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18176\/jiaci.0004","article-title":"Is the Quantification of Antigen-Specific Basophil Activation a Useful Tool for Monitoring Oral Tolerance Induction in Children With Egg Allergy","volume":"26","author":"Gamboa","year":"2016","journal-title":"J Invest Allergol Clin Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12070","article-title":"Decrease in antigen-specific CD63 basophil expression is associated with the development of tolerance to egg by SOTI in children","volume":"24","author":"Vila","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"B97","article-title":"Are basophil activation and sulphidoleukotriene determination useful tests for monitoring patients with peach allergy receiving sublingual immunotherapy with a Pru p 3-enriched peach extract","volume":"24","author":"Garrido-Fern\u00e1ndez","year":"2014","journal-title":"J Invest Allergol Clin Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.010","article-title":"Immunologic Suppression To Peanut During Immunotherapy Is Often Transient","volume":"135","author":"Gorelik","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.10.038","article-title":"Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE","author":"Tsai","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy of sublingual and oral immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.07.030","article-title":"Long-term sublingual immunotherapy for peanut allergy in children: Clinical and immunologic evidence of desensitization","volume":"144","author":"Kim","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical Efficacy and Immune Regulation With Peanut Oral Immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2017.07.007","article-title":"J-OIT group. Desensitization to a whole egg by rush oral immunotherapy improves\u00a0the quality of life of guardians: A multicenter, randomized, parallel-group, delayed-start design study","volume":"67","author":"Itoh-Nagato","year":"2018","journal-title":"Allergol Int"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/all.12905","article-title":"Oral immunotherapy with low allergenic hydrolysed egg in egg allergic children","volume":"71","author":"Giavi","year":"2016","journal-title":"Allergy"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1159\/000490804","article-title":"Oral Immunotherapy Using Partially Hydrolyzed Formula for Cow\u2019s Milk Protein Allergy: A Randomized, Controlled Trial","volume":"177","author":"Inuo","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.040","article-title":"Efficacy of baked milk oral immunotherapy in baked milk-reactive allergic patients","volume":"136","author":"Goldberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/all.12158","article-title":"A phase 1 study of heat\/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy","volume":"68","author":"Wood","year":"2013","journal-title":"Allergy"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.1083","article-title":"Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization","volume":"127","author":"Kim","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B111","article-title":"Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody","volume":"97","author":"Ishizaka","year":"1966","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11882-019-0894-y","article-title":"Biomarkers in Food Allergy Immunotherapy","volume":"19","author":"Hardy","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2013.12.006","article-title":"Predicting outcomes of oral food challenges by using the allergen-specific IgE-total IgE ratio","volume":"2","author":"Gupta","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01501.x","article-title":"Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction","volume":"62","author":"Staden","year":"2007","journal-title":"Allergy"},{"key":"B115","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12535","article-title":"Differential response in allergen-specific IgE, IgGs, and IgA levels for predicting outcome of oral immunotherapy","volume":"27","author":"Sugimoto","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14117","article-title":"Elevated serum adipsin may predict unsuccessful treatment for cows\u2019 milk allergy but other biomarkers do not","volume":"107","author":"Salmivesi","year":"2018","journal-title":"Acta Paediatr"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/all.13167","article-title":"Natural tolerance development in cow\u2019s milk allergic children: IgE and IgG4 epitope binding","volume":"72","author":"Caubet","year":"2017","journal-title":"Allergy"},{"key":"B119","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2012.10.048","article-title":"Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens","volume":"131","author":"Vickery","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13117","article-title":"IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy","volume":"30","author":"Dreskin","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.028","article-title":"Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles","volume":"143","author":"Su\u00e1rez-Fari\u00f1as","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B122","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"B125","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2012.5","article-title":"Changes in antigen-specific T-cell number and function during oral desensitization in cow\u2019s milk allergy enabled with omalizumab","volume":"5","author":"Bedoret","year":"2012","journal-title":"Mucosal Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13220","article-title":"Low-dose-oral immunotherapy for children with wheat-induced anaphylaxis","author":"Nagakura","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13469","article-title":"Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents","volume":"49","author":"Brandstr\u00f6m","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.01.022","article-title":"Changing Patient Mindsets about Non-Life-Threatening Symptoms During Oral Immunotherapy: A Randomized Clinical Trial","volume":"7","author":"Howe","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13256","article-title":"High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children","volume":"49","author":"Kulis","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13305","article-title":"Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness","volume":"49","author":"Orgel","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/all.12895","article-title":"Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness","volume":"71","author":"Wright","year":"2016","journal-title":"Allergy"},{"key":"B133","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2332\/allergolint.09-OA-0107","article-title":"Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up","volume":"59","author":"Itoh","year":"2010","journal-title":"Allergol Int"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.01.017","article-title":"Oral Immunotherapy for Egg Allergy: A Double-Blind Placebo-Controlled Study, with Postdesensitization Follow-Up","volume":"3","author":"Caminiti","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13210","article-title":"Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients","volume":"59","author":"Akashi","year":"2017","journal-title":"Pediatr Int"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jaci.2015.12.1316","article-title":"Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy","volume":"137","author":"Jones","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11882-018-0819-1","article-title":"The Multifaceted B Cell Response in Allergen Immunotherapy","volume":"18","author":"Jim\u00e9nez-Saiz","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02656.x","article-title":"IgE-binding epitopes: a reappraisal","volume":"66","author":"Aalberse","year":"2011","journal-title":"Allergy"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02745.x","article-title":"Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy","volume":"67","author":"Shamji","year":"2012","journal-title":"Allergy"},{"key":"B140","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaci.2019.09.005","article-title":"Peanut oral immunotherapy induces blocking antibodies but does not change the functional characteristics of peanut-specific IgE","volume":"145","author":"Santos","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J Pathol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(88)80029-5","article-title":"Immunobiology of IgA","volume":"12","author":"Mestecky","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"B143","unstructured":"Biochemistry, Immunoglobulin A (IgA) PatelA JialalI Treasure Island (FLStatPearls PublishingStatPearls"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.045","article-title":"Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy","volume":"129","author":"Kulis","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1159\/000361023","article-title":"Specific antibodies in oral immunotherapy for cow\u2019s milk allergy: kinetics and prediction of clinical outcome","volume":"164","author":"Savilahti","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1159\/000485891","article-title":"Low-Dose Oral Immunotherapy Using Low-Egg-Allergen Cookies for Severe Egg-Allergic Children Reduces Allergy Severity and Affects Allergen-Specific Antibodies in Serum","volume":"175","author":"Maeta","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1111\/all.12217","article-title":"Serum allergen-specific IgA is not associated with natural or induced tolerance to egg in children","volume":"68","author":"Vazquez-Ortiz","year":"2013","journal-title":"Allergy"},{"key":"B148","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2017.07.004","article-title":"Immunology of Food Allergy","volume":"47","author":"Tordesillas","year":"2017","journal-title":"Immunity"},{"key":"B149","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/pai.12498","article-title":"Food-allergic infants have impaired regulatory T-cell responses following in vivo allergen exposure","volume":"27","author":"Dang","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaci.2015.03.026","article-title":"Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects","volume":"136","author":"Patil","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jaci.2018.01.035","article-title":"Identification and analysis of peanut-specific effector T and regulatory T cells in children allergic and tolerant to peanut","volume":"141","author":"Weissler","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jaci.2013.10.054","article-title":"Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner","volume":"133","author":"Wambre","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam9171","article-title":"A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders","volume":"9","author":"Wambre","year":"2017","journal-title":"Sci Transl Med"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12537","article-title":"Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy","volume":"45","author":"Wisniewski","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.029","article-title":"Single B-cell deconvolution of peanut-specific antibody responses in allergic patients","volume":"137","author":"Hoh","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/all.12966","article-title":"High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers","volume":"72","author":"Boonpiyathad","year":"2017","journal-title":"Allergy"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.061","article-title":"Role of Der p 1-specific B cells in immune tolerance during 2\u00a0years of house dust mite-specific immunotherapy","volume":"143","author":"Boonpiyathad","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.006","article-title":"Role of regulatory B cells in immune tolerance to allergens and beyond","volume":"138","author":"van de Veen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.gastro.2011.11.039","article-title":"Peyer\u2019s patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores","volume":"142","author":"Lelouard","year":"2012","journal-title":"Gastroenterology"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.01.009","article-title":"Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation","volume":"38","author":"Farache","year":"2013","journal-title":"Immunity"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00350","article-title":"Mechanisms of Tolerance Induction by Dendritic Cells In Vivo","volume":"9","author":"Hasegawa","year":"2018","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.09.015","article-title":"Gut-tropic T cells that express integrin \u03b14\u03b27 and CCR9 are required for induction of oral immune tolerance in mice","volume":"141","author":"Cassani","year":"2011","journal-title":"Gastroenterology"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/nri3855","article-title":"Transcriptional Regulation of Innate Lymphoid Cell Fate","volume":"15","author":"Serafini","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate Lymphoid Cells: 10 Years On","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J Exp Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2019.40.4217","article-title":"Role of innate lymphoid cells in allergic diseases","volume":"40","author":"Pasha","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3482","article-title":"NK cells and type 1 innate lymphoid cells: partners in host defense","volume":"17","author":"Spits","year":"2016","journal-title":"Nat Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.021","article-title":"An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers","volume":"43","author":"Morita","year":"2015","journal-title":"Immunity"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.03.056","article-title":"IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells","volume":"138","author":"Galand","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.immuni.2019.03.023","article-title":"Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion","volume":"50","author":"Leyva-Castillo","year":"2019","journal-title":"Immunity"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.019","article-title":"IL-25 and CD4(+) TH2 cells enhance type 2 innate lymphoid cell-derived IL-13 production, which promotes IgE-mediated experimental food allergy","volume":"137","author":"Lee","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","article-title":"IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function","volume":"138","author":"Noval Rivas","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.04.006","article-title":"Clinical efficacy and immunological changes subjacent to egg oral immunotherapy","volume":"114","author":"Perez\u00e1bad","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.09.030","article-title":"Individualized, IgE-based dosing of egg oral immunotherapy is associated with the development of tolerance","volume":"105","author":"Vickery","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4168\/aair.2017.9.1.35","article-title":"Oral Food Desensitization in Children With IgE-Mediated Cow\u2019s Milk Allergy: Immunological Changes Underlying Desensitization","volume":"9","author":"Perez\u00e1bad","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/372567","article-title":"Downregulation of angiogenesis factors, VEGF and PDGF, after rapid IgE desensitization and oral immunotherapy in children with food allergy","volume":"2014","author":"Poza-Guedes","year":"2014","journal-title":"BioMed Res Int"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96525","article-title":"Histamine-releasing factor enhances food allergy","volume":"127","author":"Ando","year":"2017","journal-title":"J Clin Invest"},{"key":"B181","doi-asserted-by":"publisher","first-page":"AB248","DOI":"10.1016\/j.jaci.2017.12.786","article-title":"Can urinary tetranor-PGDM, a metabolite from prostaglandin D 2 , be used as a reliable marker for evaluating the effectiveness of oral immunotherapies for children with food allergies","volume":"141","author":"Inagaki","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12859-019-2802-9","article-title":"van den Broek TJ. A network-based approach for identifying suitable biomarkers for oral immunotherapy of food allergy","volume":"20","author":"van Bilsen","year":"2019","journal-title":"BMC Bioinf"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071492","article-title":"Molecular Approaches for Diagnosis, Therapy and Prevention of Cow\u00b4s Milk Allergy","volume":"11","author":"Linhart","year":"2019","journal-title":"Nutrients"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12567","article-title":"Anti-IgE-assisted desensitization to egg and cow\u2019s milk in patients refractory to conventional oral immunotherapy","volume":"27","author":"Martorell-Calatayud","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B185","unstructured":"MoffatC Oral Immunotherapy for Peanut Allergies"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3642","article-title":"Profiling families enrolled in food allergy immunotherapy studies","volume":"124","author":"DunnGalvin","year":"2009","journal-title":"Pediatrics"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8700-5","article-title":"Psychosocial Mediators of Change and Patient Selection Factors in Oral Immunotherapy Trials","volume":"55","author":"Dunn Galvin","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.128","article-title":"The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval","volume":"84","author":"Burke","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","author":"Patrick","year":"2007","journal-title":"Value Health"},{"key":"B190","unstructured":"US Food and Drug AdministrationResearch C for DE and. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims2020"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1186\/s40413-015-0063-2","article-title":"Mechanisms of Allergen-Specific Immunotherapy and Immune Tolerance to Allergens","volume":"8","author":"Akdis","year":"2015","journal-title":"World Allergy Organ J"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jaci.2019.07.028","article-title":"Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy","volume":"144","author":"Patil","year":"2019","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.568598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T08:46:47Z","timestamp":1697014007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.568598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":192,"alternative-id":["10.3389\/fimmu.2020.568598"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.568598","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"article-number":"568598"}}